Antiemetic extended release solid dosage forms
AssigneeRedHill Biopharma Ltd.
InventorsReza Fathi, Gilead Raday, Patrick Gosselin, Guy Goldberg
Life of this patent
Estimating the term…
Loading patent…
AssigneeRedHill Biopharma Ltd.
InventorsReza Fathi, Gilead Raday, Patrick Gosselin, Guy Goldberg
Estimating the term…
A pharmaceutical formulation includes (1) a first dosage component comprising: a core comprising a non-ionic polymer matrix, a first amount of ondansetron or an equivalent amount of an ondansetron salt thereof dispersed within the matrix, and an electrolyte dispersed within the matrix; a first seal coat surrounding the core, the first seal coat comprising a non-ionic polymer matrix; and an immediate release drug layer surrounding the first seal coat, wherein the immediate release drug layer comprises a non-ionic polymer and a second amount of ondansetron or an equivalent amount of an ondansetron salt thereof dispersed therein; and (2) a second dosage component comprising: a core comprising a third amount of ondansetron or an equivalent amount of an ondansetron salt thereof, at least one filler, and a lubricant; and a coating surrounding the core, the coating comprising water and a mixture of methacrylic acid-alkyl acrylate copolymers with alkaline groups.
A pharmaceutical formulation comprising:
Dependencies are inferred from the claim text.